Renasant financials
$39.34−1.30%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.44B | $1.09B | $910.4M | $691.1M | $695.7M | $733.7M | $695.8M | $605.8M | $506.9M | $464.5M |
| Gross profit | $985.8M | $715.9M | $632.4M | $630.6M | $651.0M | $662.3M | $596.9M | $540.5M | $469.0M | $436.4M |
| Gross margin | 68.3% | 65.6% | 69.5% | 91.2% | 93.6% | 90.3% | 85.8% | 89.2% | 92.5% | 93.9% |
| Operating income | $226.7M | $245.0M | $177.2M | $211.3M | $222.8M | $103.5M | $215.7M | $188.6M | $159.9M | $135.8M |
| Net income | $181.3M | $195.5M | $144.7M | $166.1M | $175.9M | $83.7M | $167.6M | $146.9M | $92.2M | $90.9M |
| Net margin | 12.6% | 17.9% | 15.9% | 24.0% | 25.3% | 11.4% | 24.1% | 24.3% | 18.2% | 19.6% |
| Diluted EPS | $2.07 | $3.27 | $2.56 | $2.95 | $3.12 | $1.48 | $2.88 | $2.79 | $1.96 | $2.17 |
| EBITDA | $276.1M | $258.3M | $177.2M | $213.8M | $229.3M | $111.0M | $216.0M | $202.9M | $170.5M | $142.3M |
| Operating cash flow | $271.5M | $106.4M | $148.6M | $574.0M | $142.7M | $82.2M | $163.6M | $82.1M | $207.0M | $163.8M |
| Free cash flow | $246.4M | $93.1M | $127.9M | $560.4M | $132.0M | $54.0M | $132.4M | $60.7M | $196.1M | $152.7M |
| Diluted shares | 87.5M | 59.7M | 56.4M | 56.2M | 56.4M | 56.5M | 58.2M | 52.6M | 47.0M | 42.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $299.6M | $198.4M | $206.7M | $193.5M | $182.7M | $176.4M |
| Short-term investments | $4.36B | $2.85B | $2.74B | $3.24B | $4.50B | $1.80B |
| Total debt | $1.06B | $538.6M | $737.0M | $1.14B | $485.2M | $496.3M |
| Total assets | $26.75B | $18.03B | $17.36B | $16.99B | $16.81B | $14.93B |
| Total liabilities | $22.87B | $15.36B | $15.06B | $14.85B | $14.60B | $12.80B |
| Shareholders' equity | $3.88B | $2.68B | $2.30B | $2.14B | $2.21B | $2.13B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology